Search research articles
Contact Us
Filters
Showing results (1-10 of 53) with videos related to
Page
of 6
Sort By:
Biochemical and Biophysical Research Communications
|
November 10, 2011
The role of RGS protein in agonist-dependent relaxation of GIRK currents in Xenopus oocytes
Kristoffer Sahlholm
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 26, 2021
G protein-coupled receptor kinase-2 confers isoform-specific calcium sensitivity to dopamine D<sub>2</sub> receptor desensitization
Richard Ågren, Kristoffer Sahlholm
The International Journal of Neuropsychopharmacology
|
October 29, 2025
Partial agonist antipsychotic drugs differentially interact with a secondary binding site at the dopamine D2 receptor
Richard Ågren, Kristoffer Sahlholm
Nature Communications
|
September 5, 2018
Antipsychotics with similar association kinetics at dopamine D<sub>2</sub> receptors differ in extrapyramidal side-effects
Hugo Zeberg, Kristoffer Sahlholm
Frontiers in Pharmacology
|
October 29, 2020
Voltage-Dependent Dopamine Potency at D<sub>1</sub>-Like Dopamine Receptors
Richard Ågren, Kristoffer Sahlholm
Neuro-Oncology Advances
|
September 22, 2025
ONC206 as a low-potency dopamine D<sub>2</sub> receptor antagonist
Richard Ågren, Kristoffer Sahlholm
Biomedicines
|
January 21, 2022
Evidence for Two Modes of Binding of the Negative Allosteric Modulator SB269,652 to the Dopamine D<sub>2</sub> Receptor
Richard Ågren, Kristoffer Sahlholm
The International Journal of Neuropsychopharmacology
|
July 10, 2018
The Beta-Arrestin-Biased Dopamine D2 Receptor Ligand, UNC9994, Is a Partial Agonist at G-Protein-Mediated Potassium Channel Activation
Richard Ågren, Peter Århem, Johanna Nilsson, et al.
Future Medicinal Chemistry
|
July 12, 2021
Synthetic corticosteroids as tryptophan hydroxylase stabilizers
Nibal Betari, Knut Teigen, Kristoffer Sahlholm, et al.
Biochemical and Biophysical Research Communications
|
January 7, 2018
Point mutation of a conserved aspartate, D69, in the muscarinic M<sub>2</sub> receptor does not modify voltage-sensitive agonist potency
Richard Ågren, Kristoffer Sahlholm, Johanna Nilsson, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 53) with videos related to
Sort By:
Page
of 6
Biochemical and Biophysical Research Communications
|
November 10, 2011
The role of RGS protein in agonist-dependent relaxation of GIRK currents in Xenopus oocytes
Kristoffer Sahlholm
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 26, 2021
G protein-coupled receptor kinase-2 confers isoform-specific calcium sensitivity to dopamine D<sub>2</sub> receptor desensitization
Richard Ågren, Kristoffer Sahlholm
The International Journal of Neuropsychopharmacology
|
October 29, 2025
Partial agonist antipsychotic drugs differentially interact with a secondary binding site at the dopamine D2 receptor
Richard Ågren, Kristoffer Sahlholm
Nature Communications
|
September 5, 2018
Antipsychotics with similar association kinetics at dopamine D<sub>2</sub> receptors differ in extrapyramidal side-effects
Hugo Zeberg, Kristoffer Sahlholm
Frontiers in Pharmacology
|
October 29, 2020
Voltage-Dependent Dopamine Potency at D<sub>1</sub>-Like Dopamine Receptors
Richard Ågren, Kristoffer Sahlholm
Neuro-Oncology Advances
|
September 22, 2025
ONC206 as a low-potency dopamine D<sub>2</sub> receptor antagonist
Richard Ågren, Kristoffer Sahlholm
Biomedicines
|
January 21, 2022
Evidence for Two Modes of Binding of the Negative Allosteric Modulator SB269,652 to the Dopamine D<sub>2</sub> Receptor
Richard Ågren, Kristoffer Sahlholm
The International Journal of Neuropsychopharmacology
|
July 10, 2018
The Beta-Arrestin-Biased Dopamine D2 Receptor Ligand, UNC9994, Is a Partial Agonist at G-Protein-Mediated Potassium Channel Activation
Richard Ågren, Peter Århem, Johanna Nilsson, et al.
Future Medicinal Chemistry
|
July 12, 2021
Synthetic corticosteroids as tryptophan hydroxylase stabilizers
Nibal Betari, Knut Teigen, Kristoffer Sahlholm, et al.
Biochemical and Biophysical Research Communications
|
January 7, 2018
Point mutation of a conserved aspartate, D69, in the muscarinic M<sub>2</sub> receptor does not modify voltage-sensitive agonist potency
Richard Ågren, Kristoffer Sahlholm, Johanna Nilsson, et al.
Page
of 6